Assessment of riboflavin as a tracer substance

Comparison of a qualitative to a quantitative method of riboflavin measurement

Abigail J. Herron, John J. Mariani, Martina Pavlicova, Christina M. Parrinello, Krysten W. Bold, Frances R. Levin, Edward V. Nunes, Maria A. Sullivan, Wilfred N. Raby, Adam Bisaga

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Noncompliance with medications may have major impacts on outcomes measured in research, potentially distorting the validity of controlled clinical trials. Riboflavin is frequently used in trials as a marker of adherence. It can be combined with study medication and is excreted in urine where it fluoresces under UV light. This study compares qualitative visual inspection of fluorescence to quantitative fluorometric analysis of riboflavin concentration in its ability to detect the presence of riboflavin in urine. Methods: Twenty-four volunteers received 0. mg, 25. mg, and 50. mg doses of riboflavin under single-blind conditions, with 20 also receiving a 100. mg dose. Five serial urine samples were collected over the following 36. h. Quantitative measurement of riboflavin by fluorometric analysis and qualitative assessment of each sample using visual inspection were performed. Results: The overall false positive rate for qualitative assessment was 53%. For quantitative assessment, a riboflavin concentration of 900. ng/mL was established to classify positive samples. More than 80% of samples were positive 2-24. h following ingestion of 25. mg and 50. mg, and less than 80% were positive at 36. h. At least 95% of observations for the 100. mg dose were above 900. ng/mL at all timepoints. Conclusions: Quantitative fluorometric assessment is superior to qualitative visual inspection alone in determining medication adherence. The combination of 25-50. mg of daily riboflavin and a cut-off level of 900. ng/mL allows for the acceptable sensitivity of missing detection of non-compliant participants while preserving a high level of power to detect all cases of medication compliance.

Original languageEnglish (US)
Pages (from-to)77-82
Number of pages6
JournalDrug and Alcohol Dependence
Volume128
Issue number1-2
DOIs
StatePublished - Feb 1 2013

Fingerprint

Riboflavin
Medication Adherence
Fluorometry
Inspection
Urine
Aptitude
Controlled Clinical Trials
Ultraviolet Rays
Ultraviolet radiation
Volunteers
Eating
Fluorescence
Chemical analysis
Research

Keywords

  • Adherence
  • Qualitative
  • Quantitative
  • Riboflavin
  • Tracer

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Herron, A. J., Mariani, J. J., Pavlicova, M., Parrinello, C. M., Bold, K. W., Levin, F. R., ... Bisaga, A. (2013). Assessment of riboflavin as a tracer substance: Comparison of a qualitative to a quantitative method of riboflavin measurement. Drug and Alcohol Dependence, 128(1-2), 77-82. https://doi.org/10.1016/j.drugalcdep.2012.08.007

Assessment of riboflavin as a tracer substance : Comparison of a qualitative to a quantitative method of riboflavin measurement. / Herron, Abigail J.; Mariani, John J.; Pavlicova, Martina; Parrinello, Christina M.; Bold, Krysten W.; Levin, Frances R.; Nunes, Edward V.; Sullivan, Maria A.; Raby, Wilfred N.; Bisaga, Adam.

In: Drug and Alcohol Dependence, Vol. 128, No. 1-2, 01.02.2013, p. 77-82.

Research output: Contribution to journalArticle

Herron, AJ, Mariani, JJ, Pavlicova, M, Parrinello, CM, Bold, KW, Levin, FR, Nunes, EV, Sullivan, MA, Raby, WN & Bisaga, A 2013, 'Assessment of riboflavin as a tracer substance: Comparison of a qualitative to a quantitative method of riboflavin measurement', Drug and Alcohol Dependence, vol. 128, no. 1-2, pp. 77-82. https://doi.org/10.1016/j.drugalcdep.2012.08.007
Herron, Abigail J. ; Mariani, John J. ; Pavlicova, Martina ; Parrinello, Christina M. ; Bold, Krysten W. ; Levin, Frances R. ; Nunes, Edward V. ; Sullivan, Maria A. ; Raby, Wilfred N. ; Bisaga, Adam. / Assessment of riboflavin as a tracer substance : Comparison of a qualitative to a quantitative method of riboflavin measurement. In: Drug and Alcohol Dependence. 2013 ; Vol. 128, No. 1-2. pp. 77-82.
@article{5c9b7a798c244237bef610a2091e5476,
title = "Assessment of riboflavin as a tracer substance: Comparison of a qualitative to a quantitative method of riboflavin measurement",
abstract = "Background: Noncompliance with medications may have major impacts on outcomes measured in research, potentially distorting the validity of controlled clinical trials. Riboflavin is frequently used in trials as a marker of adherence. It can be combined with study medication and is excreted in urine where it fluoresces under UV light. This study compares qualitative visual inspection of fluorescence to quantitative fluorometric analysis of riboflavin concentration in its ability to detect the presence of riboflavin in urine. Methods: Twenty-four volunteers received 0. mg, 25. mg, and 50. mg doses of riboflavin under single-blind conditions, with 20 also receiving a 100. mg dose. Five serial urine samples were collected over the following 36. h. Quantitative measurement of riboflavin by fluorometric analysis and qualitative assessment of each sample using visual inspection were performed. Results: The overall false positive rate for qualitative assessment was 53{\%}. For quantitative assessment, a riboflavin concentration of 900. ng/mL was established to classify positive samples. More than 80{\%} of samples were positive 2-24. h following ingestion of 25. mg and 50. mg, and less than 80{\%} were positive at 36. h. At least 95{\%} of observations for the 100. mg dose were above 900. ng/mL at all timepoints. Conclusions: Quantitative fluorometric assessment is superior to qualitative visual inspection alone in determining medication adherence. The combination of 25-50. mg of daily riboflavin and a cut-off level of 900. ng/mL allows for the acceptable sensitivity of missing detection of non-compliant participants while preserving a high level of power to detect all cases of medication compliance.",
keywords = "Adherence, Qualitative, Quantitative, Riboflavin, Tracer",
author = "Herron, {Abigail J.} and Mariani, {John J.} and Martina Pavlicova and Parrinello, {Christina M.} and Bold, {Krysten W.} and Levin, {Frances R.} and Nunes, {Edward V.} and Sullivan, {Maria A.} and Raby, {Wilfred N.} and Adam Bisaga",
year = "2013",
month = "2",
day = "1",
doi = "10.1016/j.drugalcdep.2012.08.007",
language = "English (US)",
volume = "128",
pages = "77--82",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Assessment of riboflavin as a tracer substance

T2 - Comparison of a qualitative to a quantitative method of riboflavin measurement

AU - Herron, Abigail J.

AU - Mariani, John J.

AU - Pavlicova, Martina

AU - Parrinello, Christina M.

AU - Bold, Krysten W.

AU - Levin, Frances R.

AU - Nunes, Edward V.

AU - Sullivan, Maria A.

AU - Raby, Wilfred N.

AU - Bisaga, Adam

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Background: Noncompliance with medications may have major impacts on outcomes measured in research, potentially distorting the validity of controlled clinical trials. Riboflavin is frequently used in trials as a marker of adherence. It can be combined with study medication and is excreted in urine where it fluoresces under UV light. This study compares qualitative visual inspection of fluorescence to quantitative fluorometric analysis of riboflavin concentration in its ability to detect the presence of riboflavin in urine. Methods: Twenty-four volunteers received 0. mg, 25. mg, and 50. mg doses of riboflavin under single-blind conditions, with 20 also receiving a 100. mg dose. Five serial urine samples were collected over the following 36. h. Quantitative measurement of riboflavin by fluorometric analysis and qualitative assessment of each sample using visual inspection were performed. Results: The overall false positive rate for qualitative assessment was 53%. For quantitative assessment, a riboflavin concentration of 900. ng/mL was established to classify positive samples. More than 80% of samples were positive 2-24. h following ingestion of 25. mg and 50. mg, and less than 80% were positive at 36. h. At least 95% of observations for the 100. mg dose were above 900. ng/mL at all timepoints. Conclusions: Quantitative fluorometric assessment is superior to qualitative visual inspection alone in determining medication adherence. The combination of 25-50. mg of daily riboflavin and a cut-off level of 900. ng/mL allows for the acceptable sensitivity of missing detection of non-compliant participants while preserving a high level of power to detect all cases of medication compliance.

AB - Background: Noncompliance with medications may have major impacts on outcomes measured in research, potentially distorting the validity of controlled clinical trials. Riboflavin is frequently used in trials as a marker of adherence. It can be combined with study medication and is excreted in urine where it fluoresces under UV light. This study compares qualitative visual inspection of fluorescence to quantitative fluorometric analysis of riboflavin concentration in its ability to detect the presence of riboflavin in urine. Methods: Twenty-four volunteers received 0. mg, 25. mg, and 50. mg doses of riboflavin under single-blind conditions, with 20 also receiving a 100. mg dose. Five serial urine samples were collected over the following 36. h. Quantitative measurement of riboflavin by fluorometric analysis and qualitative assessment of each sample using visual inspection were performed. Results: The overall false positive rate for qualitative assessment was 53%. For quantitative assessment, a riboflavin concentration of 900. ng/mL was established to classify positive samples. More than 80% of samples were positive 2-24. h following ingestion of 25. mg and 50. mg, and less than 80% were positive at 36. h. At least 95% of observations for the 100. mg dose were above 900. ng/mL at all timepoints. Conclusions: Quantitative fluorometric assessment is superior to qualitative visual inspection alone in determining medication adherence. The combination of 25-50. mg of daily riboflavin and a cut-off level of 900. ng/mL allows for the acceptable sensitivity of missing detection of non-compliant participants while preserving a high level of power to detect all cases of medication compliance.

KW - Adherence

KW - Qualitative

KW - Quantitative

KW - Riboflavin

KW - Tracer

UR - http://www.scopus.com/inward/record.url?scp=84872390160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872390160&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2012.08.007

DO - 10.1016/j.drugalcdep.2012.08.007

M3 - Article

VL - 128

SP - 77

EP - 82

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 1-2

ER -